Professor Eric C.W. SO
Visiting Research Professor, HKU and
Professor and Chair in Leukaemia Biology 
Department of Haematological Medicine
King’s College London, UK

Date: Monday, 27-November-2017
Time: 4:00 p.m.
Venue: Lecture Theatre 1, Cheung Kung Hai Conference Centre
G/F, William MW Mong Block, Faculty of Medicine Building
21 Sassoon Road, Pokfulam, Hong Kong

Summary: 
Acute myeloid leukemia (AML) is one of the most aggressive forms of cancer. While chemotherapy developed over a half century ago remains the standard treatment, it is rather ineffective in achieving long-term completion remission and AML patients generally has a very poor prognosis. Also owing to its highly toxic nature, chemotherapy is usually not applicable to older patients age over 60 and thus it leaves the majority of AML patients with no or very little treatment options. Over the past few decades, scientists have been investigating the processes leading to cancer development. Taking the advantages of relatively easy access to clinical samples and advance in cancer genetics, significant advance has been made in understanding the molecular basis of AML that helps to guide the development of more effective cancer treatment. In this lecture, Professor So will review one of the most successful examples of targeted therapy, which has transformed the highly fatal acute promyelocytic leukemia (APL) into a highly curable disease. Professor So will also discuss the recent efforts in developing novel treatments for other forms of AML that remains one of the deadliest diseases

ALL ARE WELCOME